Browse Category

Stock Market News 9 December 2025

KE Holdings (BEKE) Stock Slides as Buybacks Accelerate: What Q3 2025 Earnings and China’s Housing Slump Mean for Investors

KE Holdings (BEKE) Stock Slides as Buybacks Accelerate: What Q3 2025 Earnings and China’s Housing Slump Mean for Investors

Published 9 December 2025 KE Holdings Inc. (NYSE: BEKE), the Chinese online and offline housing platform behind Lianjia and Beike, is back in the spotlight as its stock trades lower today despite aggressive share repurchases and steady revenue growth. On Tuesday, BEKE gapped down at the open, sliding from a previous close of about $17.08 to an open near $16.35, with intraday trading around $16.27 and more than 1 million shares changing hands.MarketBeat In parallel, a Nasdaq/ETF Channel note highlighted that BEKE was among the notable decliners inside the Vanguard Total International Stock ETF (VXUS), with the stock down roughly
Summit Therapeutics (SMMT) Stock on December 9, 2025: Trial Optimism Collides With High Risk, High Volatility

Summit Therapeutics (SMMT) Stock on December 9, 2025: Trial Optimism Collides With High Risk, High Volatility

Summit Therapeutics Inc. (NASDAQ: SMMT) continues to trade like a classic high-beta biotech: big promises in lung cancer, plenty of red flags, and a stock price stuck near the lower end of its 52-week range while analysts project eye-popping upside. As of the latest US session on December 9, 2025, SMMT is trading around $17–18 per share, versus a 52-week range of $15.55 to $36.91. That means the stock is much closer to its lows than its highs, despite a steady drumbeat of bullish analyst targets and positive trial headlines. Yahoo Finance+1 Below is a rundown of the most current
Credo Technology Group (CRDO) Stock: Earnings Blowout, AI Tailwinds, and What Comes Next

Credo Technology Group (CRDO) Stock: Earnings Blowout, AI Tailwinds, and What Comes Next

Credo Technology Group Holding Ltd (NASDAQ: CRDO) has turned into one of the most closely watched semiconductor names of late, thanks to explosive earnings growth and its strategic position in high-speed connectivity for AI data centers. As of 9 December 2025, the stock is trading around $168–170 per share, down from a recent all-time high above $210 but still miles above its 52-week low near $29. Investing.com In this deep dive, we’ll walk through the latest news, earnings, analyst forecasts, and key risks so you can understand why CRDO is suddenly everywhere in markets coverage. 1. Where CRDO Stands Today
Linde plc (LIN) Stock on December 9, 2025: 52‑Week Low, CEO Buying and Double‑Digit Upside Price Targets

Linde plc (LIN) Stock on December 9, 2025: 52‑Week Low, CEO Buying and Double‑Digit Upside Price Targets

Linde plc (NASDAQ: LIN), the world’s largest industrial gases company, is having a pivotal moment in the market. On December 9, 2025, the stock is trading near fresh 52‑week lows at the same time its CEO is buying nearly $1 million worth of shares, short interest is creeping higher, and Wall Street still sees sizeable upside over the next 12 months. Below is a full roundup of today’s news, forecasts, and analysis — plus what it all could mean for Linde stock. Key takeaways for Linde stock today (9 December 2025) Linde stock price action on December 9, 2025 Market
Olema Pharmaceuticals (OLMA) Stock: Latest News, Forecast & Analysis as of December 9, 2025

Olema Pharmaceuticals (OLMA) Stock: Latest News, Forecast & Analysis as of December 9, 2025

Olema Pharmaceuticals, Inc. (Nasdaq: OLMA) has quietly turned into one of 2025’s wilder biotech stories: a tiny oncology name that’s run more than eightfold off its 52-week low, pulled back on a big equity raise, and now sits in the middle of a high-stakes bet on a single breast-cancer drug. Below is a structured look at OLMA stock today, the latest news, Street forecasts, and the key risks investors are debating as of December 9, 2025. OLMA stock today: price, performance and volatility As of the latest trade on December 9, 2025, Olema Pharmaceuticals shares change hands at around $26–27
Legend Biotech (LEGN) Stock Hits New Lows: Oversold CAR-T Leader or Long-Term Opportunity?

Legend Biotech (LEGN) Stock Hits New Lows: Oversold CAR-T Leader or Long-Term Opportunity?

As of December 9, 2025, shares of Legend Biotech Corporation (NASDAQ: LEGN) are under heavy pressure even as the company posts strong growth from its flagship CAR-T therapy, CARVYKTI. Here’s a deep dive into the latest news, forecasts, analyst calls and technical signals that are driving sentiment around Legend Biotech stock today. Where Legend Biotech Stock Trades Now Legend Biotech’s American Depositary Shares (ADS) were recently trading around $24.1, down roughly 8% on the day and hovering near fresh 52-week lows. Benzinga On December 9, 2025, the stock: A company news brief from Investing.com highlighted that Legend Biotech shares hit
Waystar Holding Corp (WAY) Hits 52-Week Low as Barclays Cuts Target – But Wall Street Still Sees Big Upside

Waystar Holding Corp (WAY) Hits 52-Week Low as Barclays Cuts Target – But Wall Street Still Sees Big Upside

December 9, 2025 Waystar Holding Corp (NASDAQ: WAY), the healthcare payments software provider, is back in the spotlight after a sharp sell-off pushed the stock to fresh 52-week lows on Tuesday, even as Wall Street analysts continue to project substantial upside over the next 12 months. Waystar Stock Today: Fresh Lows in a Volatile Session In Tuesday’s trading, Waystar shares slid to the low-$31 range, marking a new 52-week low and extending a multi-month downtrend. Intraday, the stock traded between roughly $31 and $33, down about 6% on the day and hovering just above its one-year low around $30.75.StockAnalysis+1 According
Ferguson Enterprises (FERG) Stock Slides After Q1 2026 Earnings – What Today’s Sell-Off Means for Investors

Ferguson Enterprises (FERG) Stock Slides After Q1 2026 Earnings – What Today’s Sell-Off Means for Investors

Newport News, VA – December 9, 2025 Ferguson Enterprises Inc. (NYSE: FERG; LSE: FERG) shares are under pressure today after the company reported results for the quarter ended October 31, 2025 (its fiscal Q1 2026). The numbers show solid operational momentum and raised full-year guidance, but the stock is trading sharply lower as investors digest valuations and future growth expectations. Below is a deep dive into today’s earnings, market reaction, analyst forecasts, and what it could mean for Ferguson stock going into 2026. 1. What Ferguson Reported Today Ferguson’s latest quarter was, in pure fundamental terms, strong: The company attributed
Graphic Packaging (GPK) Stock Hits 52-Week Low as Earnings Guidance Cut and CEO Transition Rattle Investors

Graphic Packaging (GPK) Stock Hits 52-Week Low as Earnings Guidance Cut and CEO Transition Rattle Investors

Graphic Packaging Holding Company (NYSE: GPK) — a major player in sustainable consumer packaging — is having a rough day on Wall Street. As of December 9, 2025, the stock has slid to a new 52-week low after the company cut its full-year earnings outlook, announced cost and production optimization measures, and confirmed a CEO transition set for early 2026. Investing.com India+1 Below is a detailed look at what’s happening with GPK stock today, the latest company news, analyst forecasts, and what the current market narrative looks like. GPK Stock Today: New 52-Week Low and Heavy Trading On December 9,
Inspire Medical Systems (INSP) Stock on December 9, 2025: Rebound Rally Meets Legal Overhang and Mixed Analyst Targets

Inspire Medical Systems (INSP) Stock on December 9, 2025: Rebound Rally Meets Legal Overhang and Mixed Analyst Targets

Inspire Medical Systems, Inc. (NYSE: INSP), a leading developer of implantable devices to treat obstructive sleep apnea, is back in the spotlight. As of December 9, 2025, the stock is trading near the upper end of its recent rebound, supported by strong third-quarter results, favorable reimbursement changes, and a series of analyst upgrades—while simultaneously facing a fresh class-action investigation and lingering questions about growth and valuation. investors.inspiresleep.com+1 INSP stock on December 9, 2025: price action and recent volatility On December 9, 2025, Inspire Medical Systems shares are changing hands at about $141.72, down slightly on the day after touching an
Advance Auto Parts (AAP) Stock Slides After Target Cut – Does the 2025 Turnaround Still Hold Up?

Advance Auto Parts (AAP) Stock Slides After Target Cut – Does the 2025 Turnaround Still Hold Up?

(for SEO):Advance Auto Parts (NYSE:AAP) stock is down sharply on December 9, 2025 after an analyst price-target cut and weak peer earnings. Here’s the latest on earnings, guidance, dividend, analyst forecasts and the ongoing three-year turnaround plan. Market snapshot: A rough day for Advance Auto Parts stock Advance Auto Parts, Inc. (NYSE: AAP) is back under pressure in Tuesday’s session (December 9, 2025). By midday, AAP shares were trading in the high-$40s, down roughly 7% on the day, in sympathy with sector peer AutoZone’s earnings miss and a fresh price-target cut from Evercore ISI.The Motley Fool+1 According to recent data,
Kontoor Brands (KTB) Stock on December 9, 2025: Q3 Beat, Analyst Upgrades and Volatile Trading Create a 2026 Upside Story

Kontoor Brands (KTB) Stock on December 9, 2025: Q3 Beat, Analyst Upgrades and Volatile Trading Create a 2026 Upside Story

As of December 9, 2025, Kontoor Brands, Inc. (NYSE: KTB) — the parent company behind Wrangler, Lee and Helly Hansen — sits in an interesting sweet spot: strong fundamentals, bullish analyst targets, but a share price that’s been knocked around by broader consumer and interest-rate worries. Below is a detailed rundown of today’s news, recent earnings, analyst forecasts and valuation debates around KTB stock, written for readers who care about both headlines and numbers. Where KTB Stock Stands Today Different data providers will print slightly different real-time prices, but today KTB is trading in the mid-$70s per share, with intraday

Stock Market Today

Corning stock price hits record close — what’s driving GLW and the next big test

Corning stock price hits record close — what’s driving GLW and the next big test

7 February 2026
Corning shares jumped 8.3% to a record $122.16 Friday, gaining 11% over two sessions amid strong demand for AI infrastructure stocks. The move follows a $6 billion optical fiber deal with Meta and upgraded company forecasts. Shares traded as high as $122.56 and rose 0.6% after hours. COO Avery Nelson sold 1,894 shares for tax withholding, retaining 66,050.
PepsiCo stock: €2.5 billion bond deal lands as investors size up the price-cut gamble

PepsiCo stock: €2.5 billion bond deal lands as investors size up the price-cut gamble

7 February 2026
PepsiCo priced €2.5 billion in euro notes across four maturities, with settlement set for Feb. 11, according to an SEC filing. The company plans to use proceeds for general corporate purposes, including repaying commercial paper. Shares closed at $170.49 Friday, up 1.8%. PepsiCo is also cutting U.S. snack prices by up to 15% after consumer pushback.
Go toTop